Beihua: plans to invest a total of 1.809 billion yuan to build two formulation projects.

Minoahua announced that the company and its subsidiaries plan to invest in the construction of a global industrial base project for high-end oral solid dosage forms and complex injections, as well as a high-activity formulation and difficult-to-soluble drugs high-end R&D project. The total investment for the two projects is 1.809 billion yuan. The total investment for the global industrial base project for high-end oral solid dosage forms and complex injections is 1.472 billion yuan, while the total investment for the high-activity formulation and difficult-to-soluble drugs high-end R&D project is 336.95 million yuan. This outbound investment still needs to be reviewed by the shareholders' meeting of the company, and is currently in the preparatory stage. The relevant implementing entities still need to complete the project filing, environmental impact assessment, energy conservation review, and other statutory approval procedures.